Activation of the PD-1 pathway for Pain therapy: A pharmaceutical mixture encompassing sucrose and naltrexone  increases the expression of PD-L1, attenuates acutes and chronic pain, and suppresses mechanical and thermal hypersensitivity and inhibits nociceptive neuron excitability via up-regulation of its target gene, 24/February/2017, 6.33 am